Clinical trial
A Phase 2a Multicenter Platform Study of Investigational Products for the Treatment of Adult Subjects With Idiopathic Pulmonary Fibrosis
NCT07230288 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2a Multicenter Platform Study of Investigational Products for the Treatment of Adult Subjects With Idiopathic Pulmonary Fibrosis
- Lead sponsor
- AbbVie
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- January 23, 2026
- Completion date
- September 30, 2029
- Enrollment
- 165 (estimated)
- Sites
- 57
Conditions
As the registry lists them; a condition with its own page is linked.